13N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripheral artery occlusive disease

Journal of Nuclear Medicine

Volumn 48, Issue 7, 2007, Pages 1216-1223

  Peñuelas, Iván ^a,c   Aranguren, Xabier L ^a,b   Abizanda, Gloria ^a,b   Martí Climent, Josep María ^a   Uriz, Maialen ^a,b   Ecay, Margarita ^a   Collantes, Maria ^a   Quincoces, Gemma ^a   Richter, José A ^a   Prósper, Felipe ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c Clinica Universitaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMMONIA N 13; BANDEIRAEA SIMPLICIFOLIA 1 LECTIN; EOSIN; HEMATOXYLIN; LECTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; CALCULATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG UPTAKE; FEMORAL ARTERY; HINDLIMB; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MATHEMATICAL ANALYSIS; MOUSE; MUSCLE NECROSIS; MYOFIBROSIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUDE MOUSE; PERFUSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AMMONIA; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; FIBROSIS; HINDLIMB; ISCHEMIA; MALE; MICE; MICE, NUDE; NECROSIS; NITROGEN RADIOISOTOPES; PERIPHERAL VASCULAR DISEASES; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW;

EID: 34447345691     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.039180     Document Type: Article

References (39)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
2. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-1264.
3. Baumgartner I, Schainfeld R, Graziani L. Management of peripheral vascular disease. Annu Rev Med. 2005;56:249-272.
4. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002;112:49-57.
5. A prospective epidemiological survey of the natural history of chronic critical leg ischaemia. The I.C.A.I. Group (gruppo di studio dell'ischemia cronica critica degli arti inferiori). Eur J Vasc Endovasc Surg. 1996;11:112-120.
6. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
7. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005;112:1618-1627.
8. Lekas M, Lekas P, Latter DA, Kutryk MB, Stewart DJ. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a reevaluation? Curr Opin Cardiol. 2006;21:376-384.
9. Waters RE, Terjung RL, Peters KG, Annex BH. Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J Appl Physiol. 2004;97:773-780.
10. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: The San Luis Valley Diahetes Study. Circulation. 1995;91:1472-1479.
11. Buschmann IR, Voskuil M, van Royen N, et al. Invasive and non-invasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease. Atherosclerosis. 2003;167:33-43.
12. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873-883.
13. Ubbink DT, Tulevski II, den Hartog D, Koelemay MJ, Legemate DA, Jacobs MJ. The value of non-invasive techniques for the assessment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 1997;13:296-300.
14. Bajnok L, Kozlovszky B, Varga J, Antalffy J, Olvaszto S, Fulop T Jr. Technetium-99m sestamibi scintigraphy for the assessment of lower extremity ischaemia in peripheral arterial disease. Eur J Nucl Med. 1994;21:1326-1332.
15. 201Tl scintigraphy can detect exercise lower limb perfusion abnormalities in asymptomatic diabetic patients with normal Doppler pressure indices. Nucl Med Commun. 2001;22:949-954.
16. 201Tl. Eur J Nucl Med. 1984;9:12-16.
17. Miles KA, Barber RW, Wraight EP, Cooper M, Appleton DS. Leg muscle scintigraphy with 99Tcm-MIBI in the assessment of peripheral vascular (arterial) disease. Nucl Med Commun. 1992;13:593-603.
18. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
19. Baumgartner I, Thoeny HC, Kummer O. et al. Leg ischemia: assessment with MR angiography and spectroscopy. Radiology. 2005;234:833-841.
20. 99mTc-MIBI in early stages of atherosclerosis. Nucl Med Rev Cent East Eur. 2006;9:18-23.
21. Surti S, Karp JS, Perkins AE, et al. Imaging performance of A-PET: a small animal PET camera. IEEE Trans Med Imaging. 2005;24:844-852.
22. Celen YZ, Zincirkeser S, Akdemir I, Yilmaz M. Investigation of perfusion reserve using 99Tc(m)-MIBI in the lower limbs of diabetic patients. Nucl Med Commun. 2000;21:817-822.
23. Luttun A, Lupu F, Storkebaum E, et al. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprolein E-deficient mice. Arterioscler Thromb Vasc Biol. 2002;22:499-505.
24. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol. 1998;152:1667-1679.
25. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res. 2004;95:449-458.
26. Bellina CR, Parodi O, Camici P, et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med. 1990;31:1335-1343.
27. 13N-ammonia and positron emission tomography. Eur J Nucl Med. 1982;7:422-425.
28. Tack CJ, van Gurp PJ, Holmes C, Goldstein DS. Local sympathetic denervation in painful diabetic neuropathy. Diabetes. 2002;51:3545-3553.
29. 201Tl scintigraphy. AJR. 1981; 137:373-380.
30. Dabrowski J, Mikosinski J, Kusmierek J. Scintigraphic and ultrasonographic assessment of the effect of lumbar sympathectomy upon chronic arteriosclerotic ischaemia of lower extremities. Nucl Med Rev Cent East Eur. 2003;6:17-22.
31. Sayman HB, Urgancioglu I. Muscle perfusion with technetium-MIBI in lower extremity peripheral arterial diseases. J Nucl Med. 1991;32:1700-1703.
32. Li W, Shen W, Gill R, et al. High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb. Circulation. 2006;113:2445-2453.
33. Pu LQ, Jackson S, Lachapelle KJ, et al. A persistent hindlimb ischemia model in the rabbit. J Invest Surg. 1994;7:49-60.
34. Boger RH, Bode-Boger SM, Thiele W, Creutzig A, Alexander K, Frolich JC. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol. 1998;32:1336-1344.
35. Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol. 1999;154:355-363.
36. Couffinhal T, Silver M, Kearney M, et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation. 1999;99:3188-3198.
37. Duan J, Murohara T, Ikeda H, et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation. 2000;102:III370-III376.
38. Duan J, Murohara T, Ikeda H, et al. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol. 2000;20: 2579-2585.
39. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation. 1999;99:111-120.